Posted
July 18 - A Reuters analysis finds the largest shareholders of biotechs bought into the companies at such low costs, they'll likely be willing sellers in a takeover bid and could make billions in profits.
02:03
02:17
01:07
00:58
01:53
01:19
02:03
01:54
01:39
02:04
01:13
01:36
01:53
01:05
03:46
02:05
01:09
00:40
01:33
01:21
01:09
00:26
01:54
01:43
01:30
02:44
01:56
00:45
00:59
00:52
00:45
01:50
01:21
02:19
02:22
00:36
00:35
01:08
02:25
01:16
01:19
01:58
01:12
00:35
01:48
02:57
01:36
02:00
01:25
02:44
00:48
01:18
00:45
02:49
02:16
01:16